Lab-cultured cardiac cells

Three types of human heart cells have been grown from cultures derived from embryonic stem cells, by a team of Canadian, US and UK scientists.

During the research, when a mix of the cells was transplanted into mice with simulated heart disease, the animals’ heart function was significantly improved, according to research published in the journal Nature.
The embryonic stem cell cultures were carefully supplied with a staged cocktail of growth factors and other molecules involved in development, and grew into immature versions of cardiomyocytes, endothelial cells and vascular smooth muscle cells, each important constituents of heart muscle. ‘This development means that we can efficiently and accurately make different types of human heart cells for use in both basic and clinical research, said researcher Dr Gordon Keller, of the McEwen Centre for Regenerative Medicine in Toronto. ‘The immediate impact of this is significant, as we now have an unlimited supply of these cells to study how they develop, how they function and how they respond to different drugs. In the future, the cells may also be very effective in developing new strategies for repairing damaged hearts, following a heart attack.’

30.04.2008

More on the subject:

Related articles

Photo

News • Neuroscience

Possible biomarker for suicidal thoughts identified

Researchers identified a possible biomarker linked to severe suicidal thoughts. It may also help explain why some people recover, opening a new path for research into resilience and prevention.

Photo

News • iPSC-derived assembloids

Heart valve organoid to advance understanding of cardiac conditions

In a first for the field, a team has grown heart valves on organoids. This work is an important step toward better understanding—and treating—a number of serious heart disorders.

Photo

Sponsored • Produced in partnership with FUJIFILM Wako

Putting β-glucan testing into everyday practice for fungal infections

Invasive fungal infections are notoriously hard to catch early, and even harder to rule out with confidence. At CHU Bordeaux, Dr Frédéric Gabriel has spent years refining how his lab uses…

Subscribe to Newsletter